Lipitor: The Case of a Blockbuster Drug
|
Code : BSM0002
|
Region : USA
|
||||
 |
 |
 |
 OR |
||
|
Abstract: The major driver of the pharmaceutical industry is R&D. While research and innovation costs increase, companies are pressurised to improve their R&D productivity. To leverage on their investments and research capabilities, companies turn to mergers and acquisitions. But consolidation has always decelerated R&D productivity. The industry has become increasingly dependent on blockbuster drugs. Most blockbusters that emerged are cardiovascular drugs. Statins belong to this class. Lipitor, a statin, was discovered and developed by Warner Lambert and quickly became a blockbuster. |
|
| For Case Books
Click Here >> For Case eBooks Click Here >> |
|
Pedagogical Objectives:
Keywords : Lipitor; R&D; Drug; Blockbuster; Zocor; Pfizer; Warner Lambert; Pharmaceutical industry; Food and Drug Administration; Innovation Management Case Study; Celebrex; Generics; Mergers and acquisitions; Atorvastatin; Patent; US pharma industry
Contents :
» The pursuit of blockbusters
» The Discovery and Development of Lipitor Statins – A new Therapeutical Market
» The Path to Market Success
Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org
©2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map 